Last reviewed · How we verify
HNC664 capsules Single dose
At a glance
| Generic name | HNC664 capsules Single dose |
|---|---|
| Also known as | HNC664 capsules |
| Sponsor | Guangzhou Henovcom Bioscience Co. Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of HNC664 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |